deferoxamine has been researched along with malondialdehyde in 111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (18.92) | 18.7374 |
| 1990's | 50 (45.05) | 18.2507 |
| 2000's | 22 (19.82) | 29.6817 |
| 2010's | 14 (12.61) | 24.3611 |
| 2020's | 4 (3.60) | 2.80 |
| Authors | Studies |
|---|---|
| Lepinski, DL; Pellmar, TC | 1 |
| Kawai, S; Okuyama, T; Tomita, M; Ueki, A; Watanabe, H | 1 |
| Abdallah, MA; Brissot, P; Cillard, J; Cillard, P; Lescoat, G; Morel, I; Ocaktan, AZ; Pasdeloup, N; Sergent, O | 1 |
| Green, JW; Hulgan, TM; Jenkins, LD; Moore, RB | 1 |
| Khan, S; O'Brien, PJ; Ramwani, JJ | 1 |
| Azodi, M; Dollwet, H; Dunphy, G; Ely, D; Richter, H; Sellke, F | 1 |
| Bhuyan, DK; Bhuyan, KC; Chiu, W; Fridovich, I; Malik, S | 1 |
| Daryani, R; Demling, R; Knox, J; LaLonde, C; Youn, YK; Zhu, D | 1 |
| Bubrick, MP; Jacobs, DM; Julsrud, JM | 1 |
| Gemba, M; Kameyama, Y | 1 |
| Dobbin, P; Hershko, C; Hider, RC; Link, G; Peter, HH; Pinson, A | 1 |
| Das, DK; George, A; Iyengar, J; Russell, JC | 1 |
| Costa, D; Fontecave, M; Jaouen, M; Mansuy, D; Pezerat, H; Zalma, R | 1 |
| Evans, PF; King, LJ; Parke, DV; Preece, NE | 1 |
| Strubelt, O; Younes, M | 1 |
| Demling, RH; LaLonde, C | 1 |
| Sareen, S; Singal, PK; Tiede, R | 1 |
| Bacon, BR; Britton, RS; Dalton, N; Magiera, CJ; O'Neill, R; Park, CH; Sharma, BK; Smanik, P; Speroff, T | 1 |
| Reed, DJ; Thomas, CE | 2 |
| Kako, KJ; Matsuoka, T; Yanagishita, T | 1 |
| Bacon, BR; Grisham, MB; Inauen, W; Kvietys, PR | 1 |
| Lemoine, R; Sause, C; Siegers, CP; Younes, M | 1 |
| Braquet, P; Garay, RP; Maridonneau-Parini, I | 1 |
| Towell, JF; Wang, RI | 1 |
| Fuller, BJ; Hobbs, KE; Innes, GK | 1 |
| Aust, SD; Bicknell, JS; Goosmann, M; Krause, GS; March, GG; Nayini, NR; White, BC | 1 |
| Casini, AF; Comporti, M; Ferrali, M; Maellaro, E; Pompella, A | 1 |
| Freed, BM; Lempert, N; Patterson, DA; Patterson, MA; Rapoport, R | 1 |
| Arey, BJ; Mahanty, S; Schwarz, KB; Tolman, K | 1 |
| Paller, MS | 1 |
| Angel, MF; Basford, RE; Futrell, JW; Kuhns, DB; Narayanan, K; Ramasastry, SS; Swartz, WM | 1 |
| Cederbaum, AI; Krikun, G | 1 |
| Aust, SD; Bialek, H; Evans, AT; Huang, RR; Indrieri, RJ; Jacobs, WA; Komara, J; Nayini, NR; White, BC | 1 |
| Ceccarelli-Stanzani, D; Masini, A; Trenti, T; Ventura, E | 1 |
| Bialick, HA; Evans, AT; Garritano, AM; Hoehner, TJ; Huang, RR; Indrieri, RJ; Jacobs, WA; Komara, JS; Krause, GS; Nayini, NR | 1 |
| Hershko, C; Link, G; Pinson, A | 1 |
| Clark, IA; Cowden, WB; Hunt, NH; Mackie, EJ; Maxwell, LE | 2 |
| Demling, R; Ikegami, K; LaLonde, C | 1 |
| Günther, T; Höllriegl, V; Vormann, J | 1 |
| Borle, AB; Caraceni, P; Van Thiel, DH | 1 |
| Harada, T; Hiraishi, H; Yajima, N | 1 |
| Abadie, C; David, M; Eicher, JC; Gabrielle, F; Maupoil, V; Rochette, L; Wolf, JE | 1 |
| Angel, MF; Babovic, S; Dellon, AL; Im, MJ; Manson, PN; Ress, AM | 1 |
| Lightbody, JH; McMaster, D; Tate, S; Trimble, ER; Young, IS | 1 |
| Cillard, J; Cillard, P; Lescoat, G; Morel, I | 1 |
| Magni, F; Panduri, G; Paolocci, N | 1 |
| Boadle, RA; Harris, DC; Nankivell, BJ; Tay, YC | 1 |
| Lee, HP; Ong, CN; Shen, HM; Shi, CY | 1 |
| Klee, S; Nürnberger, MC; Ungemach, FR | 1 |
| Bianchetti, A; Cini, M; Fariello, RG; Moretti, A | 1 |
| Borle, AB; Caraceni, P; Rosenblum, ER; Van Thiel, DH | 1 |
| de Jeu-Jaspars, NC; de Rooy, FW; Koster, JF; Siersema, PD; van Eijk, HG; van Gelder, W; Voogd, A; Wilson, JH | 1 |
| Aitken, RJ; Buckingham, DW; Harkiss, D | 1 |
| Athias, P; Grynberg, A; Hershko, C; Kaltwasser, JP; Link, G; Pinson, A; Tzahor, M | 1 |
| Bredl, CR; Gmur, DJ; Schimpf, BA; Zager, RA | 1 |
| Babbs, CF; Pham, J; Salaris, SC | 1 |
| Azorin, I; Bella, MC; Fornas, E; Iborra, FJ; Renau-Piqueras, J | 1 |
| Courtiere, A; Molard, F; Reybaud, J | 1 |
| Faux, SP; Howden, PJ | 1 |
| Hagen, K; Hultcrantz, R; Ingelman-Sundberg, M; Johansson, I; Stål, P | 1 |
| Bhattacharya, M; Chemtob, S; Hanna, N; Hardy, P; Lachapelle, P; Ponka, P; Varma, DR | 1 |
| Furukawa, Y; Sugiyama, M; Susa, N; Ueno, S | 1 |
| Huang, XQ; McAnulty, JF | 1 |
| Cènas, N; Dickancaité, E; Kalvelytè, A; Nemeikaitè, A | 1 |
| Bickel, KD; Borschel, G; Girotto, JA; Im, MJ; Marin, PC | 1 |
| Furuno, K; Shimomichi, K; Suetsugu, T; Sugihara, N; Tsuruta, Y | 1 |
| Baan, J; Dorrepaal, CA; Moison, R; Shadid, M; Steendijk, P; Van Bel, F; Van Der Velde, ET | 1 |
| Hironaka, K; Okita, K; Sakaida, I; Uchida, K | 1 |
| Boffi, FM; Inanami, O; Kuwabara, M; Matsuki, N; Ono, K; Takanohashi, A | 1 |
| Carbonell, T; Mitjavila, MT; Ródenas, J | 1 |
| Coskun, E; Demir, S; Suzer, T; Tahta, K | 1 |
| Brown, PA; Chatterjee, PK; Cuzzocrea, S; Mota-Filipe, H; Stewart, KN; Thiemermann, C; Zacharowski, K | 1 |
| Goto, K; Irukayama-Tomobe, Y; Lazaratos, S; Miyauchi, T; Nakahara, A | 1 |
| Barberi, I; Cuzzocrea, S; Fulia, F; Gitto, E; Karbownik, M; Manchester, LC; Reiter, RJ; Tan, DX | 1 |
| Dunster, C; Grieve, DJ; Kelly, FJ; Li, JM; MacCarthy, PA; Shah, AM | 1 |
| Acuña-Castroviejo, D; García, JJ; Martínez-Ballarín, E; Millán-Plano, S; Ortega-Gutiérrez, S; Reiter, RJ; Robinson, M | 1 |
| Balogh, N; Gaál, T; Krausz, F; Lévai, P; Ribiczeyné, PS; Vajdovich, P | 1 |
| Che, CT; Ip, SP; Sun, HD; Yang, H | 1 |
| Higuchi, A; Koreeda, A; Tsunenari, S; Yonemitsu, K | 1 |
| Ak, A; Bariskaner, H; Dogan, N; Gurbilek, M; Ustun, ME; Yosunkaya, A | 1 |
| Grune, T; Gutzeit, C; Jakstadt, M; Jung, T; Marschinke, F; Pilgrimm, H; Stroh, A; Zimmer, C | 1 |
| Li, PQ; Lu, H; Lu, Z; Xu, O; Zhang, X | 1 |
| Gou, L; Liu, J; Wang, Z; Zhuang, J | 1 |
| Kahraman, A; Polat, C; Sabuncuoğlu, B; Tokyol, C; Yìlmaz, S | 1 |
| Azizova, OA; Baranova, OA; Bekman, EM; Danilogorskaya, YA; Gubareva, EV; Moskvina, SN; Shulenina, LV | 1 |
| Bloomer, SA; Brown, KE; Buettner, GR; Kregel, KC | 1 |
| Andreadou, I; Arkadopoulos, N; Kalimeris, K; Karvouni, E; Kostopanagiotou, G; Kouskouni, E; Panagopoulos, D; Routsi, C; Smyrniotis, V; Vlahakos, D | 1 |
| Arkadopoulos, NP; Kalimeris, KA; Kostopanagiotou, GG; Lekka, ME; Nakos, G; Pafiti, A; Panagopoulos, D; Routsi, C; Smyrniotis, V; Vlahakos, D | 1 |
| Hao, L; Lehmann, A; Liu, L; Neuhaus, P; Nussler, A; Nussler, N; Song, F; Yao, P; Zhao, J | 1 |
| Aydin, A; Bulucu, F; Inal, V; Karadurmus, N; Kenar, L; Koc, B; Ocal, R; Oktenli, C; Sahin, M; Yaman, H; Yamanel, L | 1 |
| Chupyrkina, AA; Isaev, NK; Pevzner, IB; Plotnikov, EY; Zorov, DB | 1 |
| Lan, YH; Lim, TM; Tan, EK; Zhou, ZD | 1 |
| Feng, M; Jin, C; Li, Y; Liu, XY; Tao, LD; Zhang, PJ; Zhou, B | 1 |
| Garcia, AJ; Khan, SA; Kumar, GK; Prabhakar, NR; Ramirez, JM | 1 |
| Chu, L; Gao, Y; Guan, P; Ma, J; Ma, Z; Wang, J; Wang, N; Zhang, J; Zhang, X; Zhang, Y | 1 |
| Aksu, B; Aksu, F; Ayvaz, S; Basaran, UN; Cemek, M; Inan, M; Karaboga, I; Karaca, T; Pul, M | 1 |
| Atabey, C; Demirel, D; Dinc, C; Eroglu, A; Ipcioglu, O; Iplikcioglu, AC; Topuz, K | 1 |
| De Boer, B; Delriviere, L; Huang, WH; Jeffrey, GP; Mou, LJ; Niu, X | 1 |
| Cao, JB; Li, YF; Mi, WD; Zhang, LM; Zhang, XY | 1 |
| Chu, L; Chu, X; Cui, L; Liu, Y; Liu, Z; Wang, H; Zhang, J; Zhang, Y | 1 |
| Caputa, M; Kletkiewicz, H; Mila-Kierzenkowska, C; Nowakowska, A; Rogalska, J; Siejka, A; Woźniak, A | 2 |
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Kumfu, S | 1 |
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Khamseekaew, J; Kumfu, S; Srichairatanakool, S; Sripetchwandee, J; Wongjaikam, S | 1 |
| Mohammadi, E; Nasseri, E; Qujeq, D; Tamaddoni, A; Zand, H; Zayeri, F | 1 |
| Gao, J; Li, H; Li, Y; Liu, Z; Sun, F; Wang, X; Zhao, X | 1 |
| Chen, H; Li, NS; Luo, XJ; Peng, J; Tang, LJ; Tu, H; Xiong, XM | 1 |
| Chao, H; Li, D; Zhang, M | 1 |
| Chen, K; Jiang, C; Jiang, Z; Qi, G; Wang, H; Yan, Z | 1 |
1 trial(s) available for deferoxamine and malondialdehyde
| Article | Year |
|---|---|
Benefits of Curcumin Supplementation on Antioxidant Status in β-Thalassemia Major Patients: A Double-Blind Randomized Controlled Clinical Trial.
Topics: Adult; Antioxidants; beta-Thalassemia; Biomarkers; Curcumin; Deferoxamine; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Malondialdehyde; Oxidative Stress; Young Adult | 2017 |
110 other study(ies) available for deferoxamine and malondialdehyde
| Article | Year |
|---|---|
Electrophysiological consequences of exposure of hippocampal slices to dihydroxyfumarate, a generator of superoxide radicals.
Topics: Animals; Catalase; Deferoxamine; Dimethyl Sulfoxide; Electrophysiology; Evoked Potentials; Fumarates; Guinea Pigs; Hippocampus; In Vitro Techniques; Male; Malondialdehyde; Neurons; Reference Values; Superoxide Dismutase; Superoxides; Synapses | 1992 |
Combined action of paraquat and superoxide on the peroxidation of detergent-dispersed linolenic acid.
Topics: Cyclic N-Oxides; Deferoxamine; Detergents; Drug Synergism; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Linolenic Acids; Lipid Peroxidation; Malondialdehyde; Paraquat; Superoxides | 1992 |
Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Topics: Animals; Antioxidants; Calcium-Binding Proteins; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Deferiprone; Deferoxamine; Ethanol; Free Radical Scavengers; Free Radicals; Hydroxides; Hydroxyl Radical; Iron; Iron Chelating Agents; Kinetics; Lipid Peroxidation; Liver; Malondialdehyde; Oligopeptides; Photolysis; Pigments, Biological; Pyridones; Rats; Rats, Sprague-Dawley | 1992 |
Increased susceptibility of the sickle cell membrane Ca2+ + Mg(2+)-ATPase to t-butylhydroperoxide: protective effects of ascorbate and desferal.
Topics: Anemia, Sickle Cell; Ascorbic Acid; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Calmodulin; Deferoxamine; Erythrocyte Membrane; Ethylmaleimide; Hemoglobins; Humans; Iron; Kinetics; Malondialdehyde; Membrane Proteins; Molecular Weight; Oxidation-Reduction; Peroxides; Polymers; tert-Butylhydroperoxide | 1992 |
Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation.
Topics: Alkylating Agents; Animals; Antioxidants; Butylated Hydroxyanisole; Cell Death; Cyclic N-Oxides; Deferoxamine; Glutathione; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mechlorethamine; Rats; Rats, Inbred Strains; Vitamin E | 1992 |
Maintenance of left ventricular function (90%) after twenty-four-hour heart preservation with deferoxamine.
Topics: Animals; Creatine Kinase; Deferoxamine; Diastole; Heart; In Vitro Techniques; Malondialdehyde; Myocardial Contraction; Myocardial Reperfusion; Organ Preservation; Rats; Rats, Inbred SHR; Ventricular Function, Left | 1992 |
Desferal-Mn(III) in the therapy of diquat-induced cataract in rabbit.
Topics: Animals; Ascorbic Acid; Cataract; Deferoxamine; Diquat; Free Radicals; Glutathione; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Kinetics; Lens, Crystalline; Lipid Peroxidation; Malondialdehyde; Membrane Lipids; Organ Culture Techniques; Organometallic Compounds; Rabbits | 1991 |
Fluid resuscitation with deferoxamine prevents systemic burn-induced oxidant injury.
Topics: Animals; Burns; Deferoxamine; Edema; Fluid Therapy; Hydroxides; Hydroxyethyl Starch Derivatives; Isotonic Solutions; Lipid Peroxidation; Liver; Lung; Malondialdehyde; Oxygen; Oxygen Consumption; Ringer's Lactate; Sheep | 1991 |
Iron chelation with a deferoxamine conjugate in hemorrhagic shock.
Topics: Animals; Aspartate Aminotransferases; Chelating Agents; Deferoxamine; Hemodynamics; Hydroxyethyl Starch Derivatives; Iron; Liver; Malondialdehyde; Resuscitation; Shock, Hemorrhagic; Survival Analysis; Swine; Time Factors | 1991 |
The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.
Topics: Animals; Cisplatin; Deferoxamine; Glutathione; Iron; Iron Chelating Agents; Kidney Cortex; Lipid Peroxidation; Male; Malondialdehyde; Rats; Rats, Inbred Strains | 1991 |
Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
Topics: Animals; Cell Membrane; Cells, Cultured; Deferoxamine; Iron; Iron Chelating Agents; Kinetics; Lipid Peroxidation; Malondialdehyde; Myocardium; Pyridones; Rats | 1991 |
The effects of an iron chelator on cellular injury induced by vascular stasis caused by hypothermia.
Topics: Animals; Creatine Kinase; Deferoxamine; Hindlimb; Hydroxides; Hydroxyl Radical; Hypothermia, Induced; Iron; L-Lactate Dehydrogenase; Lipid Peroxides; Malondialdehyde; Muscles; Necrosis; Rabbits; Regional Blood Flow; Reperfusion Injury; Temperature | 1990 |
Microsomal lipid peroxidation and oxy-radicals formation are induced by insoluble iron-containing minerals.
Topics: Animals; Carbon Dioxide; Carbonates; Catalase; Cyclic N-Oxides; Deferoxamine; Ferric Compounds; Ferrosoferric Oxide; Free Radical Scavengers; Hydroxides; Hydroxyl Radical; Iron; Lipid Peroxidation; Male; Malondialdehyde; Microsomes, Liver; Minerals; Oxides; Oxygen; Rats; Rats, Inbred Strains; Silicic Acid; Spin Labels; Sulfides; Superoxide Dismutase | 1990 |
Effects of glutathione depletion, chelation and diuresis on iron nitrilotriacetate-induced lipid peroxidation in rats and mice.
Topics: Animals; Buthionine Sulfoximine; Chelating Agents; Deferoxamine; Diuretics; Ferric Compounds; Furosemide; Glutathione; Kidney; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine Sulfoximine; Nitrilotriacetic Acid; Oxidation-Reduction; Rats; Rats, Inbred Strains; Species Specificity | 1990 |
The role of iron and glutathione in t-butyl hydroperoxide-induced damage towards isolated perfused rat livers.
Topics: Alanine Transaminase; Animals; Calcium; Chemical and Drug Induced Liver Injury; Deferoxamine; Glutamate Dehydrogenase; Glutathione; In Vitro Techniques; Iron; L-Lactate Dehydrogenase; Liver; Male; Malondialdehyde; Mitochondria, Liver; Perfusion; Peroxides; Rats; Rats, Inbred Strains; tert-Butylhydroperoxide | 1990 |
Identification and modifications of the pulmonary and systemic inflammatory and biochemical changes caused by a skin burn.
Topics: Allopurinol; Animals; Burns; Deferoxamine; Hemodynamics; Ibuprofen; Lipid Peroxidation; Liver; Lung; Malondialdehyde; Sheep | 1990 |
Transferrin delays oxygen radical induced cardiac-contractile failure.
Topics: Animals; Basement Membrane; Deferoxamine; Free Radicals; Heart Failure; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Contraction; Myocardium; Oxygen Consumption; Rats; Rats, Inbred Strains; Transferrin; Xanthine Oxidase | 1990 |
Prevention of hepatocyte injury and lipid peroxidation by iron chelators and alpha-tocopherol in isolated iron-loaded rat hepatocytes.
Topics: Animals; Apoproteins; Cell Survival; Cells, Cultured; Deferoxamine; Iron; Lipid Peroxidation; Liver; Male; Malondialdehyde; Microscopy, Electron; Rats; Rats, Inbred Strains; Reference Values; Transferrin; Vitamin E | 1990 |
Effect of extracellular Ca++ omission on isolated hepatocytes. II. Loss of mitochondrial membrane potential and protection by inhibitors of uniport Ca++ transduction.
Topics: Animals; Calcium; Cells, Cultured; Deferoxamine; Glutathione; Kinetics; L-Lactate Dehydrogenase; Lanthanum; Liver; Male; Malondialdehyde; Membrane Potentials; Mitochondria, Liver; Rats; Rats, Inbred Strains; Ruthenium; Ruthenium Red; Submitochondrial Particles; Vitamin E | 1988 |
Effects of leukocyte-derived oxidants on sarcolemmal Na,K,ATP-ase and calcium transport.
Topics: Animals; Biological Transport, Active; Calcium; Cells, Cultured; Deferoxamine; Dithiothreitol; Hydrogen Peroxide; Hypochlorous Acid; Kidney Medulla; Kinetics; Leukocytes; Malonates; Malondialdehyde; Myocardium; Ouabain; Rats; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Swine | 1989 |
Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical.
Topics: Animals; Deferoxamine; Endothelium, Vascular; Free Radicals; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Hypoxanthine; Hypoxanthines; Intracellular Membranes; Iron; Malondialdehyde; Xanthine Oxidase | 1989 |
Effect of deferrioxamine and diethyldithiocarbamate on paracetamol-induced hepato- and nephrotoxicity. The role of lipid peroxidation.
Topics: Acetaminophen; Animals; Creatinine; Deferoxamine; Ditiocarb; Ethane; Glutathione; Kidney; Lipid Peroxides; Liver; Male; Malondialdehyde; Mice | 1988 |
Heterogeneous effect of flavonoids on K+ loss and lipid peroxidation induced by oxygen-free radicals in human red cells.
Topics: Cell Membrane Permeability; Deferoxamine; Ditiocarb; Erythrocytes; Flavonoids; Free Radicals; Humans; In Vitro Techniques; Lipid Peroxides; Malondialdehyde; Potassium; Superoxide Dismutase | 1986 |
Hydrogen peroxide-induced glutathione depletion and aldehyde dehydrogenase inhibition in erythrocytes.
Topics: Aldehyde Dehydrogenase; Animals; Catalase; Deferoxamine; Erythrocytes; Female; Glutathione; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Lipid Peroxides; Male; Malondialdehyde; Oxidation-Reduction; Rabbits | 1987 |
Lipid peroxidation in hepatocyte cell cultures: modulation by free radical scavengers and iron.
Topics: Animals; Cell Survival; Cells, Cultured; Culture Media; Deferoxamine; Iron; L-Lactate Dehydrogenase; Lipid Peroxides; Liver; Male; Malondialdehyde; Mannitol; Rats; Urea | 1988 |
Effect of extracellular Ca++ omission on isolated hepatocytes. I. Induction of oxidative stress and cell injury.
Topics: Animals; Antioxidants; Calcium; Cells, Cultured; Deferoxamine; Egtazic Acid; Kinetics; L-Lactate Dehydrogenase; Liver; Male; Malondialdehyde; Phenylenediamines; Rats; Rats, Inbred Strains | 1988 |
Effect on biochemical markers of brain injury of therapy with deferoxamine or superoxide dismutase following cardiac arrest.
Topics: Animals; Brain Chemistry; Deferoxamine; Dogs; Heart Arrest; Lipid Peroxidation; Malondialdehyde; Potassium; Resuscitation; Sodium; Superoxide Dismutase | 1988 |
Lipid peroxidation, protein thiols and calcium homeostasis in bromobenzene-induced liver damage.
Topics: Alanine Transaminase; Animals; Bromobenzenes; Calcium; Deferoxamine; Glutathione; Homeostasis; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Necrosis; Proteins; Sulfhydryl Compounds | 1988 |
Hydrogen peroxide-mediated inhibition of T-cell response to mitogens is a result of direct action on T cells.
Topics: Deferoxamine; Humans; Hydrogen Peroxide; Lymphocyte Activation; Malondialdehyde; Mitogens; Monocytes; T-Lymphocytes | 1988 |
Iron chelation as a possible mechanism for aspirin-induced malondialdehyde production by mouse liver microsomes and mitochondria.
Topics: Animals; Aspirin; Deferoxamine; Dose-Response Relationship, Drug; Electric Conductivity; Iron Chelating Agents; Lipid Peroxides; Male; Malonates; Malondialdehyde; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mitochondria, Liver | 1988 |
Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Deferoxamine; Disease Models, Animal; Glycerol; Hemoglobins; Iron; Kidney; Lipid Peroxides; Male; Malondialdehyde; Myoglobin; Rats; Rats, Inbred Strains | 1988 |
Deferoxamine increases skin flap survival: additional evidence of free radical involvement in ischaemic flap surgery.
Topics: Animals; Deferoxamine; Free Radicals; Graft Survival; Male; Malondialdehyde; Necrosis; Rats; Rats, Inbred Strains; Skin; Surgical Flaps; Xanthine Oxidase | 1986 |
Effect of chronic ethanol consumption on microsomal lipid peroxidation. Role of iron and comparison between controls.
Topics: Alcoholism; Animals; Deferoxamine; Diet; Ethanol; Iron; Lipid Peroxides; Male; Malondialdehyde; Microsomes, Liver; Rats | 1986 |
Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest.
Topics: Animals; Brain Ischemia; Deferoxamine; Dogs; Free Radicals; Heart Arrest; Iron Chelating Agents; Lidoflazine; Lipid Peroxides; Malonates; Malondialdehyde; Oxygen; Time Factors | 1985 |
The effect of ferric iron complex on isolated rat liver mitochondria. I. Respiratory and electrochemical responses.
Topics: Animals; Butylated Hydroxytoluene; Chromans; Deferoxamine; Dose-Response Relationship, Drug; Edetic Acid; Electrochemistry; Energy Metabolism; Ferric Compounds; Iron; Malondialdehyde; Membrane Potentials; Mitochondria, Liver; Oligomycins; Oxygen Consumption; Rats | 1985 |
Brain iron delocalization and lipid peroxidation following cardiac arrest.
Topics: Analysis of Variance; Animals; Brain; Deferoxamine; Dogs; Heart Arrest; Infusions, Parenteral; Iron; Lipid Peroxides; Malondialdehyde; Models, Biological; Resuscitation | 1986 |
Heart cells in culture: a model of myocardial iron overload and chelation.
Topics: Animals; Cells, Cultured; Chelating Agents; Deferoxamine; Ferritins; Heart Diseases; Hemochromatosis; Iron; Iron Radioisotopes; Lipid Peroxides; Malondialdehyde; Myocardium; Rats; Rats, Inbred Strains; Temperature; Transferrin | 1985 |
Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency.
Topics: Animals; Deferoxamine; Erythrocytes; Favism; Female; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Hemolysis; Malaria; Male; Malondialdehyde; Mice; Mice, Inbred CBA; Microscopy, Electron; Pyrimidinones | 1984 |
Radical-mediated damage to parasites and erythrocytes in Plasmodium vinckei infected mice after injection of t-butyl hydroperoxide.
Topics: Animals; Deferoxamine; Erythrocytes; Female; Free Radicals; Glutathione; Hemolysis; Malaria; Male; Malondialdehyde; Mice; Peroxides; Plasmodium; tert-Butylhydroperoxide | 1984 |
Aerosolized deferoxamine prevents lung and systemic injury caused by smoke inhalation.
Topics: Acute Disease; Administration, Inhalation; Aerosols; Animals; Bronchoalveolar Lavage Fluid; Carboxyhemoglobin; Deferoxamine; Disease Models, Animal; Extravascular Lung Water; Female; Hydroxyethyl Starch Derivatives; Lipid Peroxides; Lung; Malondialdehyde; Respiration; Sheep; Smoke Inhalation Injury | 1994 |
Effects of magnesium and iron on lipid peroxidation in cultured hepatocytes.
Topics: Animals; Ascorbic Acid; Cells, Cultured; Culture Media; Deferoxamine; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Ferrous Compounds; Free Radicals; Lipid Peroxidation; Liver; Magnesium; Malondialdehyde; Rats; Reactive Oxygen Species; Time Factors | 1995 |
Dual effect of deferoxamine on free radical formation and reoxygenation injury in isolated hepatocytes.
Topics: Acridines; Aerobiosis; Anaerobiosis; Animals; Cell Separation; Deferoxamine; L-Lactate Dehydrogenase; Liver; Luminescent Measurements; Male; Malondialdehyde; Oxygen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 1995 |
Protection of cultured rat gastric cells against oxidant stress by iron chelation. Role of lipid peroxidation.
Topics: Animals; Cells, Cultured; Chromium Radioisotopes; Deferoxamine; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Iron Chelating Agents; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Peroxides; Phenanthrolines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; tert-Butylhydroperoxide | 1995 |
Experimental preservation of the heart transplant: effects of deferoxamine on functional recovery and lipid peroxidation of the isolated-perfused rat heart subjected to ischemia and reperfusion.
Topics: Animals; Deferoxamine; Heart; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organ Preservation; Perfusion; Rats; Rats, Wistar | 1995 |
Free radical damage in acute nerve compression.
Topics: Animals; Antioxidants; Deferoxamine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Free Radicals; Lipid Peroxidation; Malondialdehyde; Nerve Compression Syndromes; Pregnatrienes; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sciatic Nerve | 1995 |
The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat.
Topics: Animals; Ascorbic Acid; Blood Glucose; Cholesterol; Copper; Deferoxamine; Diabetes Mellitus, Experimental; Erythrocyte Membrane; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Insulin; Insulin, Regular, Pork; Iron; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Recombinant Proteins; Reference Values; Serum Albumin; Triglycerides; Vitamin A; Vitamin E | 1995 |
Role of flavonoids and iron chelation in antioxidant action.
Topics: Animals; Antioxidants; Catechin; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Techniques; Deferoxamine; Flavonoids; Iron; Iron Chelating Agents; Lipid Peroxidation; Liver; Malondialdehyde; Quercetin; Rats; Rats, Sprague-Dawley | 1994 |
Hypothermia triggers iron-dependent lipoperoxidative damage in the isolated rat heart.
Topics: Animals; Blood Pressure; Creatine Kinase; Deferoxamine; Electrocardiography; Female; Glutathione; Heart; Hypothermia, Induced; In Vitro Techniques; Iron; Iron Chelating Agents; Lipid Peroxidation; Male; Malondialdehyde; Mycotoxins; Myocardium; Perfusion; Pyrones; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Time Factors; Ventricular Function, Left | 1994 |
Dietary protein alters tubular iron accumulation after partial nephrectomy.
Topics: Animals; Deferoxamine; Dietary Proteins; Glomerular Filtration Rate; Glutathione; Iron; Kidney; Kidney Tubules; Lysosomes; Male; Malondialdehyde; Nephrectomy; Rats; Rats, Wistar; Reactive Oxygen Species; Transferrin | 1994 |
Aflatoxin B1-induced lipid peroxidation in rat liver.
Topics: Aflatoxin B1; Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Deferoxamine; Dose-Response Relationship, Drug; Lipid Peroxidation; Liver; Male; Malondialdehyde; Rats; Rats, Inbred F344; Selenium; Vitamin E | 1994 |
The consequences of nitrofurantoin-induced oxidative stress in isolated rat hepatocytes: evaluation of pathobiochemical alterations.
Topics: Acetylcysteine; Animals; Carmustine; Deferoxamine; Dithiothreitol; Glutathione; Glutathione Reductase; L-Lactate Dehydrogenase; Liver; Male; Malondialdehyde; Nitrofurantoin; Oxidation-Reduction; Rats; Rats, Wistar; Stress, Physiological | 1994 |
Studies on lipid peroxidation in the rat brain.
Topics: Allopurinol; Animals; Antioxidants; Brain; Chromans; Deferoxamine; Ferrous Compounds; Kinetics; Lipid Peroxidation; Male; Malondialdehyde; Oxazines; Piperazines; Rats; Rats, Wistar; Vitamin E | 1994 |
Reoxygenation injury in isolated rat hepatocytes: relation to oxygen free radicals and lipid peroxidation.
Topics: Acridines; Allopurinol; Animals; Antimycin A; Cell Hypoxia; Cells, Cultured; Deferoxamine; Free Radicals; Horseradish Peroxidase; Hydrogen Peroxide; Kinetics; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Luminescent Measurements; Luminol; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Regression Analysis; Superoxides; Time Factors; Vitamin E | 1994 |
The effect of desferrioxamine on iron metabolism and lipid peroxidation in hepatocytes of C57BL/10 mice in experimental uroporphyria.
Topics: Animals; Deferoxamine; Iron; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Porphyrias; Porphyrins; Uroporphyrinogen Decarboxylase | 1993 |
Analysis of lipid peroxidation mechanisms in human spermatozoa.
Topics: Deferoxamine; Edetic Acid; Ferrous Compounds; Humans; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Reactive Oxygen Species; Spectrophotometry; Spermatozoa; Thiobarbiturates | 1993 |
Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Deferoxamine; Doxorubicin; Drug Synergism; Heart; Iron; L-Lactate Dehydrogenase; Malondialdehyde; Myocardium; Rats | 1993 |
Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.
Topics: Adenosine Triphosphate; Animals; Antimycin A; Cell Hypoxia; Deferoxamine; Iron; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley | 1993 |
Traumatic versus postischemic induction of oxidative stress in rat liver.
Topics: Animals; Calcimycin; Deferoxamine; Ischemia; Liver; Male; Malondialdehyde; Organ Culture Techniques; Oxygen; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 1993 |
Effect of tert-butyl hydroperoxide addition on spontaneous chemiluminescence in brain.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Deferoxamine; Edetic Acid; Female; Histocytochemistry; Iron; Lipid Peroxidation; Luminescent Measurements; Malondialdehyde; NADPH-Ferrihemoprotein Reductase; Peroxides; Rats; Rats, Wistar; tert-Butylhydroperoxide; Thiobarbituric Acid Reactive Substances | 1995 |
Differential effects of in vitro peroxidation on peripheral- and central-type benzodiazepine receptors. Protection by diverse antioxidants.
Topics: Animals; Antioxidants; Ascorbic Acid; Benzodiazepinones; Brain; Cell Membrane; Chromans; Deferoxamine; Edetic Acid; Ferrous Compounds; Flunitrazepam; Hypolipidemic Agents; Lipid Peroxidation; Liver; Malondialdehyde; Receptors, GABA-A; Rutin; Vitamin E | 1995 |
Fibre-induced lipid peroxidation leads to DNA adduct formation in Salmonella typhimurium TA104 and rat lung fibroblasts.
Topics: Acetylcysteine; Animals; Antidotes; Asbestos, Crocidolite; Asbestos, Serpentine; Buthionine Sulfoximine; Carcinogens; Deferoxamine; DNA; DNA Adducts; Enzyme Inhibitors; Ferrozine; Fibroblasts; Glass; Glutathione; Lipid Peroxidation; Lung; Malondialdehyde; Methionine Sulfoximine; Mineral Fibers; Rats; Salmonella typhimurium; Thiobarbituric Acid Reactive Substances | 1996 |
Hepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation.
Topics: Alanine Transaminase; Animals; Antidotes; Blotting, Western; Cytochrome P-450 CYP2E1; Deferoxamine; Drug Therapy, Combination; Ethanol; Glutathione; Iron; Iron Overload; Lipid Peroxidation; Liver; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley | 1996 |
Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Deferoxamine; Disease Models, Animal; Electroretinography; Humans; Hydrogen Peroxide; Infant, Newborn; Iron Chelating Agents; Isoniazid; Malondialdehyde; Oxidative Stress; Peroxides; Pyridoxal; Retina; Swine; Vision Disorders | 1997 |
Protective effect of deferoxamine on chromium (VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes.
Topics: Alkaline Phosphatase; Animals; Antidotes; Ascorbic Acid; Caustics; Cells, Cultured; Deferoxamine; DNA Damage; DNA, Single-Stranded; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; Malondialdehyde; Potassium Dichromate; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin E | 1997 |
The efficacy of antioxidants administered during low temperature storage of warm ischemic kidney tissue slices.
Topics: Animals; Antioxidants; Ascorbic Acid; Chromans; Cryopreservation; Deferoxamine; Ischemia; Kidney Cortex; Malondialdehyde; Rabbits; Tissue Preservation | 1997 |
Prooxidant character of flavonoid cytotoxicity: structure-activity relationships.
Topics: Animals; Antioxidants; Cell Death; Cell Line, Transformed; Chelating Agents; Deferoxamine; Flavonoids; HL-60 Cells; Humans; Lipid Peroxidation; Malondialdehyde; Oxidants; Oxidation-Reduction; Oxidative Stress; Phenylenediamines; Sheep; Structure-Activity Relationship | 1998 |
Effects of hydroxyethyl-starch-bound deferoxamine on ischemia/reperfusion injury in chronic nerve compression.
Topics: Animals; Deferoxamine; Hydroxyethyl Starch Derivatives; Iron Chelating Agents; Male; Malondialdehyde; Nerve Compression Syndromes; Premedication; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sciatic Nerve | 1998 |
Lipid peroxidation induced by adriamycin in linolenic acid-loaded cultured hepatocytes.
Topics: 7-Alkoxycoumarin O-Dealkylase; alpha-Linolenic Acid; Animals; Antibiotics, Antineoplastic; Antioxidants; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; Malondialdehyde; Phenylenediamines; Proadifen; Rats; Rats, Wistar; Vitamin E | 1998 |
Effect of deferoxamine on post-hypoxic-ischemic reperfusion injury of the newborn lamb heart.
Topics: Animals; Animals, Newborn; Ascorbic Acid; Chelating Agents; Deferoxamine; Dehydroascorbic Acid; Female; Heart; Hypoxia; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxidation-Reduction; Sheep | 1999 |
Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats.
Topics: Alanine Transaminase; Amino Acids; Animals; Choline Deficiency; Deferoxamine; Diet; Iron Chelating Agents; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Precancerous Conditions; Rats; Rats, Wistar; Time Factors | 1999 |
Hydroxyl radical generation and lipid peroxidation in C2C12 myotube treated with iodoacetate and cyanide.
Topics: Animals; Cell Line; Cyclic N-Oxides; Deferoxamine; Drug Resistance; Electron Spin Resonance Spectroscopy; Hydroxyl Radical; Iodoacetates; Iron Chelating Agents; Kinetics; L-Lactate Dehydrogenase; Lipid Peroxidation; Malondialdehyde; Mice; Muscle, Skeletal; Sodium Cyanide; Spin Labels; Superoxide Dismutase | 1999 |
Different roles for nitrogen monoxide and peroxynitrite in lipid peroxidation induced by activated neutrophils.
Topics: Animals; Arginine; Carrageenan; Deferoxamine; Exudates and Transudates; Granuloma; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Nitrates; Nitric Oxide; Ornithine; Oxidants; Pentetic Acid; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides | 2000 |
Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine.
Topics: Analysis of Variance; Animals; Brain; Chelating Agents; Deferoxamine; Epilepsy; Ferrous Compounds; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Random Allocation; Rats; Trimetazidine; Vasodilator Agents | 2000 |
Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
Topics: Acute Kidney Injury; Animals; Cell Membrane Permeability; Cell Separation; Cells, Cultured; Chelating Agents; Cyclic N-Oxides; Deferoxamine; Disease Models, Animal; Free Radical Scavengers; Hydrogen Peroxide; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Malondialdehyde; Necrosis; Oxidants; Oxidative Stress; Peroxidase; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Reperfusion Injury; Spin Labels; Tyrosine | 2000 |
Oxygen radicals mediate the final exacerbation of endothelin-1-induced gastric ulcer in rat.
Topics: Adenosine Triphosphate; Aldehydes; Allopurinol; Animals; Catalase; Deferoxamine; Disease Progression; Endothelin-1; Gastric Mucosa; Male; Malondialdehyde; Oxypurinol; Peptic Ulcer; Probucol; Rats; Rats, Wistar; Regional Blood Flow; Superoxide Dismutase; Superoxides; Vasoconstriction; Xanthine Oxidase | 2001 |
Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates.
Topics: Animals; Antioxidants; Ascorbic Acid; Cell Membrane; Deferoxamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; In Vitro Techniques; Lipid Peroxidation; Lipids; Malondialdehyde; Melatonin; Proteins; Rats; Vitamin E | 2001 |
Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase.
Topics: Animals; Antioxidants; Arginine; Ascorbic Acid; Biopterins; Deferoxamine; Drug Synergism; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Guinea Pigs; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Malondialdehyde; Metalloporphyrins; Myocardial Contraction; NADPH Oxidases; Oxidation-Reduction; Reactive Oxygen Species; Substance P | 2001 |
Melatonin improves deferoxamine antioxidant activity in protecting against lipid peroxidation caused by hydrogen peroxide in rat brain homogenates.
Topics: Animals; Antioxidants; Brain; Deferoxamine; Hydrogen Peroxide; Iron Chelating Agents; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Rats; Rats, Sprague-Dawley | 2002 |
Effect of deferoxamine and L-arginine treatment on lipid peroxidation in an intestinal ischaemia-reperfusion model in rats.
Topics: Animals; Arginine; Deferoxamine; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Female; Glutathione Peroxidase; Ischemia; Jejunum; Lipid Peroxidation; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Reperfusion; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2002 |
Dihydroisotanshinone I protects against menadione-induced toxicity in a primary culture of rat hepatocytes.
Topics: Animals; Antioxidants; Ascorbic Acid; Cell Survival; Cells, Cultured; Deferoxamine; Free Radical Scavengers; Glutathione; Hepatocytes; Lipid Peroxidation; Malondialdehyde; NAD(P)H Dehydrogenase (Quinone); Phenanthrenes; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Sprague-Dawley; Salvia; Superoxides; Vitamin K 3 | 2002 |
Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation--a mechanism of protective effects of EGCg against paraquat toxicity.
Topics: Animals; Antioxidants; Catechin; Cyclic N-Oxides; Deferoxamine; Drug Interactions; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Herbicides; Iron Chelating Agents; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Microsomes, Liver; Paraquat; Rats; Rats, Wistar; Spin Trapping; Superoxides; Tea | 2003 |
Effects of deferoxamine on tissue lactate and malondialdehyde levels in cerebral ischemia.
Topics: Acute Disease; Animals; Brain; Brain Ischemia; Deferoxamine; Electroencephalography; Iron Chelating Agents; Lactic Acid; Male; Malondialdehyde; Rabbits | 2003 |
Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages.
Topics: Animals; Antioxidants; Carbon; Cell Division; Cells, Cultured; Deferoxamine; Electron Spin Resonance Spectroscopy; Ferric Compounds; Free Radicals; Iron; Iron Chelating Agents; Lipid Peroxidation; Macrophages; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Malondialdehyde; Microscopy, Confocal; Oxidative Stress; Protons; Rats; Time Factors | 2004 |
[Effect of combination of Ginkgo leaf extract and deferoxamine in preventing and treating ototoxicity of cisplatin].
Topics: Animals; Cisplatin; Cochlea; Deferoxamine; Drug Synergism; Drugs, Chinese Herbal; Evoked Potentials, Auditory, Brain Stem; Female; Ginkgo biloba; Guinea Pigs; Male; Malondialdehyde; Random Allocation; Superoxide Dismutase | 2004 |
[Putative mechanism of experimental immunological liver injury and influence of iron low-load on the injury in rat].
Topics: Animals; Deferoxamine; Disease Models, Animal; Iron; Iron Deficiencies; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Diseases; Male; Malondialdehyde; Mycobacterium bovis; Phlebotomy; Rats; Rats, Wistar; Superoxide Dismutase | 2004 |
The effects of desferrioxamine and quercetin on hepatic ischemia-reperfusion induced renal disturbance.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Deferoxamine; Glutathione; Kidney; Liver; Male; Malondialdehyde; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Reperfusion Injury; Time | 2006 |
Evaluation of the resistance of blood plasma to oxidative stress by oxidizability of proteins and lipids during metal-catalyzed oxidation.
Topics: Buffers; Catalysis; Chelating Agents; Copper; Cross-Linking Reagents; Deferoxamine; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Fibrinogen; Hydrogen-Ion Concentration; Iron; Lipid Metabolism; Malondialdehyde; Metals; Oxidation-Reduction; Oxidative Stress; Plasma; Protein Carbonylation; Proteins; Sodium Chloride; Spectrometry, Fluorescence; Time Factors | 2006 |
Dysregulation of hepatic iron with aging: implications for heat stress-induced oxidative liver injury.
Topics: Age Factors; Aging; Animals; Deferoxamine; Disease Models, Animal; Ferritins; Heat Stress Disorders; Homeostasis; Hyperthermia, Induced; Iron; Iron Chelating Agents; Iron-Dextran Complex; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors | 2008 |
Iron chelation attenuates intracranial pressure and improves survival in a swine model of acute liver failure.
Topics: Animals; Brain; Central Venous Pressure; Cytokines; Deferoxamine; Disease Models, Animal; Female; Intracranial Hypertension; Liver; Liver Failure, Acute; Malondialdehyde; Siderophores; Swine | 2008 |
Desferrioxamine attenuates minor lung injury following surgical acute liver failure.
Topics: Acute Lung Injury; Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Catalase; Deferoxamine; Female; Infusions, Intravenous; Liver Failure, Acute; Malondialdehyde; Necrosis; Nitrates; Nitrites; Oxidative Stress; Phospholipases A2; Proteins; Random Allocation; Swine | 2009 |
The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage.
Topics: Allyl Compounds; Bilirubin; Carbon Monoxide; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Deferoxamine; Disulfides; Enzyme Inhibitors; Ethanol; Ferrous Compounds; Glutathione; Heme Oxygenase-1; Hemoglobins; Hepatocytes; Humans; Iron; L-Lactate Dehydrogenase; Liver Diseases, Alcoholic; Malondialdehyde; Organometallic Compounds; Protoporphyrins; Quercetin; Transaminases | 2009 |
Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity.
Topics: Acetylcysteine; Animals; Catalase; Copper; Deferoxamine; Doxorubicin; Glutathione Peroxidase; Iron; Lipid Peroxidation; Liver; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Selenium; Superoxide Dismutase; Zinc | 2009 |
Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria.
Topics: Animals; Antioxidants; Cell Respiration; Deferoxamine; Free Radical Scavengers; Humans; Iron Chelating Agents; Kidney Tubules; Male; Malondialdehyde; Mitochondria; Myoglobin; Myoglobinuria; Nitric Oxide; Oxidative Stress; Plastoquinone; Rats; Rhabdomyolysis | 2009 |
Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: implications for iron-related dopaminergic neuron degeneration.
Topics: Antioxidants; Cell Death; Cell Line; Cell Survival; Deferoxamine; Dopamine; Ferric Compounds; Ferrous Compounds; Glutathione; Humans; Indolequinones; Iron Chelating Agents; Malondialdehyde; Melanins; Oxidation-Reduction; Proteasome Inhibitors; Siderophores | 2010 |
Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats.
Topics: Amylases; Animals; Deferoxamine; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lipase; Liver Transplantation; Malondialdehyde; Microscopy; Pancreas; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2011 |
Hydrogen peroxide differentially affects activity in the pre-Bötzinger complex and hippocampus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Biophysics; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Ferrous Compounds; GABA Antagonists; Hippocampus; Hydrogen Peroxide; In Vitro Techniques; Lipid Peroxidation; Malondialdehyde; Mice; Neurons; Oxidants; Patch-Clamp Techniques; Picrotoxin; Piperazines; Respiratory Center; Siderophores | 2011 |
Mechanism of protective effects of Danshen against iron overload-induced injury in mice.
Topics: Alanine Transaminase; Animals; Animals, Outbred Strains; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspartate Aminotransferases; Deferoxamine; Disease Models, Animal; Drugs, Chinese Herbal; Glutathione Peroxidase; Hepatocytes; Iron Overload; Iron-Dextran Complex; Liver; Male; Malondialdehyde; Mice; Phenanthrolines; Phytotherapy; Salvia miltiorrhiza; Superoxide Dismutase | 2013 |
Desferrioxamine reduces oxidative stress in the lung contusion.
Topics: Animals; Deferoxamine; Glutathione; Glutathione Peroxidase; Immunohistochemistry; Lung Injury; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2013 |
Comparison of deferoxamine and methylprednisolone: protective effect of pharmacological agents on lipid peroxidation in spinal cord injury in rats.
Topics: Animals; Catalase; Combined Modality Therapy; Deferoxamine; Glutathione Peroxidase; Laminectomy; Lipid Peroxidation; Logistic Models; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Siderophores; Spinal Cord; Spinal Cord Injuries; Superoxide Dismutase | 2013 |
Iron-induced oxidative rat liver injury after non-heart-beating warm ischemia is mediated by tumor necrosis factor α and prevented by deferoxamine.
Topics: Adenosine; Allopurinol; Animals; Aspartate Aminotransferases; Bile; Deferoxamine; Disease Models, Animal; F2-Isoprostanes; Glutathione; Heart Arrest; Insulin; Iron; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Malondialdehyde; Organ Preservation Solutions; Oxidative Stress; Perfusion; Raffinose; Rats; Tumor Necrosis Factor-alpha; Warm Ischemia | 2014 |
Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.
Topics: Animals; Caspase 3; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Exploratory Behavior; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Interleukin-1beta; Iron; Lipopolysaccharides; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Reaction Time; Siderophores; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2015 |
Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice.
Topics: Animals; Collagen Type I; Collagen Type III; Deferoxamine; Drugs, Chinese Herbal; Endomyocardial Fibrosis; Iron; Iron Overload; Iron-Dextran Complex; Malondialdehyde; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; Mice; Oxidative Stress; Plant Extracts; Random Allocation; Salvia miltiorrhiza; Superoxide Dismutase; Transforming Growth Factor beta1; Verapamil | 2015 |
Deferoxamine prevents cerebral glutathione and vitamin E depletions in asphyxiated neonatal rats: role of body temperature.
Topics: Animals; Animals, Newborn; Body Temperature; Brain; Deferoxamine; Female; Glutathione; Hyperthermia, Induced; Hypoxia; Male; Malondialdehyde; Rats; Rats, Wistar; Vitamin E | 2016 |
Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
Topics: Animals; Benzoates; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular Diseases; Deferasirox; Deferiprone; Deferoxamine; Dihydropyridines; Heart; Iron Chelating Agents; Iron Overload; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitochondria; Nitrophenols; Organophosphorus Compounds; Pyridones; Thalassemia; Triazoles | 2016 |
Deferoxamine improves antioxidative protection in the brain of neonatal rats: The role of anoxia and body temperature.
Topics: Animals; Animals, Newborn; Antioxidants; Body Temperature; Brain; Catalase; Deferoxamine; Female; Glutathione Peroxidase; Hypoxia; Male; Malondialdehyde; Rats; Rats, Wistar; Siderophores; Superoxide Dismutase-1 | 2016 |
Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.
Topics: Acetylcysteine; Animals; Benzoates; Cardiomyopathies; Cardiotonic Agents; Deferasirox; Deferiprone; Deferoxamine; Drug Combinations; Drug Synergism; Humans; Iron; Iron Chelating Agents; Iron Overload; Iron, Dietary; Male; Malondialdehyde; Mitochondria; Pyridones; Rats; Rats, Wistar; Triazoles; Ventricular Function, Left | 2016 |
Inhibition of ferroptosis attenuates busulfan-induced oligospermia in mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Busulfan; Cation Transport Proteins; Cyclohexylamines; Cyclooxygenase 2; Deferoxamine; Ferroptosis; Male; Malondialdehyde; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Oligospermia; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Sperm Motility; Testis | 2020 |
Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion.
Topics: Animals; Biomarkers; Coenzyme A Ligases; Creatine Kinase; Deferoxamine; Ferroptosis; Iron; Ischemia; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Phospholipid Hydroperoxide Glutathione Peroxidase; Rats, Sprague-Dawley; Siderophores | 2021 |
Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Deferoxamine; Female; Ferric Compounds; Ferroptosis; Humans; Interleukin-6; Iron; Malondialdehyde; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Quaternary Ammonium Compounds; Tumor Necrosis Factor-alpha | 2021 |
Iron overload-induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: An in vitro and in vivo study.
Topics: Animals; Deferoxamine; Dextrans; Ferroptosis; Glutathione; Iron; Iron Overload; Malondialdehyde; Mice; Osteoblasts; Osteogenesis; Osteoporosis; Reactive Oxygen Species; Superoxide Dismutase; X-Ray Microtomography | 2022 |